Takebe N - Search Results

1

Experimental therapies: Investigator-initiated cancer trials with INDs for approval in Japan.

Imamura CK, Takebe N, Nakamura S, Saya H, Ueno NT. Imamura CK, et al. Among authors: takebe n. Nat Rev Clin Oncol. 2010 Mar;7(3):127-8. doi: 10.1038/nrclinonc.2010.13. Nat Rev Clin Oncol. 2010. PMID: 20190792 No abstract available.

2

International models of investigator-initiated trials: implications for Japan.

Trimble EL, Ledermann J, Law K, Miyata T, Imamura CK, Nam BH, Kim YH, Bang YJ, Michaels M, Ardron D, Amano S, Ando Y, Tominaga T, Kurokawa K, Takebe N. Trimble EL, et al. Among authors: takebe n. Ann Oncol. 2012 Dec;23(12):3151-3155. doi: 10.1093/annonc/mds168. Epub 2012 Jul 25. Ann Oncol. 2012. PMID: 22843420 Free PMC article.

3

Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer.

Yamauchi T, Espinosa Fernandez JR, Imamura CK, Yamauchi H, Jinno H, Takahashi M, Kitagawa Y, Nakamura S, Lim B, Krishnamurthy S, Reuben JM, Liu D, Tripathy D, Chen H, Takebe N, Saya H, Ueno NT. Yamauchi T, et al. Among authors: takebe n. Oncotarget. 2018 Jan 4;9(6):6872-6882. doi: 10.18632/oncotarget.23914. eCollection 2018 Jan 23. Oncotarget. 2018. PMID: 29467936 Free PMC article.

4

Advances in Oncology in US and Japan: Focusing on Cancer and Infectious Diseases.

Nakano H, Miyamoto T, Janjigian YY, Mine S, Mitsuya H, Ueno NT, Sharon E, Sakai S, Timmer WC, Nakabo S, Ikeuchi T, Fujiwara S, Kinjo M, Inuzuka T, Kume H, Shirai K, Yamaguchi N, Takabe K, Takebe N. Nakano H, et al. Among authors: takebe n. World J Oncol. 2021 Dec;12(6):183-194. doi: 10.14740/wjon1422. Epub 2021 Dec 13. World J Oncol. 2021. PMID: 35059078 Free PMC article. Review.

5

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.

Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX, Ivy SP. Takebe N, et al. Nat Rev Clin Oncol. 2015 Aug;12(8):445-64. doi: 10.1038/nrclinonc.2015.61. Epub 2015 Apr 7. Nat Rev Clin Oncol. 2015. PMID: 25850553 Free PMC article. Review.

6

Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.

Bando H, Takebe N. Bando H, et al. Among authors: takebe n. Jpn J Clin Oncol. 2015 Nov;45(11):1001-6. doi: 10.1093/jjco/hyv144. Epub 2015 Sep 29. Jpn J Clin Oncol. 2015. PMID: 26423340 Free PMC article. Review.

7

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Takebe N, Harris PJ, Warren RQ, Ivy SP. Takebe N, et al. Nat Rev Clin Oncol. 2011 Feb;8(2):97-106. doi: 10.1038/nrclinonc.2010.196. Epub 2010 Dec 14. Nat Rev Clin Oncol. 2011. PMID: 21151206 Review.

8

Biomarkers: exceptional responders-discovering predictive biomarkers.

Takebe N, McShane L, Conley B. Takebe N, et al. Nat Rev Clin Oncol. 2015 Mar;12(3):132-4. doi: 10.1038/nrclinonc.2015.19. Epub 2015 Feb 17. Nat Rev Clin Oncol. 2015. PMID: 25687910 No abstract available.

9

Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.

Clara JA, Monge C, Yang Y, Takebe N. Clara JA, et al. Among authors: takebe n. Nat Rev Clin Oncol. 2020 Apr;17(4):204-232. doi: 10.1038/s41571-019-0293-2. Epub 2019 Dec 2. Nat Rev Clin Oncol. 2020. PMID: 31792354 Review.

10

NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide.

Minig L, Trimble EL, Birrer MJ, Kim KY, Takebe N, Abrams JS. Minig L, et al. Among authors: takebe n. Gynecol Oncol. 2010 Feb;116(2):177-80. doi: 10.1016/j.ygyno.2009.10.046. Epub 2009 Nov 3. Gynecol Oncol. 2010. PMID: 19889449 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters